It all adds up: how a term extension can be impacted if a patent covers more than one pharmaceutical substance

A recent Federal Court decision has further considered Australia’s patent term extension (PTE) provisions. Merck Sharp & Dohme (MSD) is the registered proprietor of Australian patent 2002320303, which relates to the treatment or prevention of diabetes. 

Read more on page 10 >>